Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

ICON COMPOSER 2 AND SF SYMBOLS 8 NOW AVAILABLE AS BETAS

Apple has released beta versions of SF Symbols 8 and Icon Composer 2 for developers and designers following WWDC26. SF Symbols 8 adds new symbols across Apple's latest operating systems, bringing the total library to more than 7,000 symbols with support for animations, effects, and variable rendering. Icon Composer 2 introduces Liquid Glass design tools such as Refraction for realistic light distortion, improved specular highlights for better layer definition, and an Extended Preview mode that lets designers see how app icons will appear on both current and previous operating systems.

A FRONTIER WITHOUT AN ECOSYSTEM IS NOT STABLE

The AI industry should be building a frontier ecosystem so that value flows broadly across every company, industry, and country. This ecosystem would own the learning loop that encodes its institutional knowledge, compounding its human and token capital. Platforms enable more value on top than is captured inside. Once implemented, companies will be able to create value for themselves and for the economy around them.

NUCLEAR CLOCKS TICK FOR THE FIRST TIME

Chinese and European research teams working independently have both achieved building a working nuclear clock. Both exploit the nucleus of a thorium-229 atom to keep time with extraordinary precision. Building a working nuclear clock has so far proven to be challenging, as the required laser light sits in a part of the spectrum that is technically challenging to generate and control. The Chinese team used a more powerful laser, while the European team worked with a crystal containing a higher concentration of the thorium nuclei.

NEW CRISPR TECHNIQUE SELECTIVELY SHREDS CANCER CELLS, INCLUDING “UNDRUGGABLE” CANCERS

Researchers have created a new CRISPR-based approach that can selectively destroy cells carrying a mutation in a tumor suppressor found in nearly half of cancers and up to 70% to 90% of cases of some of the most difficult-to-treat cancers. The new approach harnesses CRISPR's ability to find cells with specific mutations and uses its cutting ability to selectively destroy those cells. Making treatments for different cancers using this technique is faster than making a small molecule drug or antibody therapy. Delivery remains a challenge, but a combination of therapies may prove useful for some cancers.

TLDR IndexPage 1